Evidence map›Paper›PMID 41645718›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Expandable Nanocomposite Shape-Memory Hemostat for the Treatment of Noncompressible Hemorrhage.

Saptarshi Biswas, Sarah E Miller, Shounak Roy, Jeevika Thazhaiselvam, Samantha Foster, Manivannan Sivaperuman Kalairaj, Sasha M George, Yava Jones-Hall, Staci J Horn, Fred J Clubb and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Saptarshi BiswasDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Sarah E MillerDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Shounak RoyDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-9698-6956
Jeevika ThazhaiselvamCollege of Veterinary Medicine and Biomedical Sciences, College Station, Texas A&M University, College Station, Texas, USA.
Samantha FosterInterdisciplinary Program in Genetics, College Station, Texas A&M University, College Station, Texas, USA.
Manivannan Sivaperuman KalairajDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Sasha M GeorgeDepartment of Material Science and Engineering, College of Engineering, College Station, Texas A&M University, College Station, Texas, USA.
Yava Jones-HallCollege of Veterinary Medicine and Biomedical Sciences, College Station, Texas A&M University, College Station, Texas, USA.
Staci J HornDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Fred J ClubbCollege of Veterinary Medicine and Biomedical Sciences, College Station, Texas A&M University, College Station, Texas, USA.
Taylor H WareDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Duncan J MaitlandDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Akhilesh K GaharwarDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-0284-0201

Funding

Engineered Living Materials for the Delivery of Engineered Probiotics and TherapeuticsR56EB032395 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI WARE, TAYLOR H · 2022 to 2022
$788k
American Heart Association under a Predoctoral Fellowship 24PRE1200460NIBIB NIH HHS R56EB032395Peer Reviewed Medical Research Program (PRMRP) of the Department of Defense (DOD) W81XWH2210932
6 · The paper itself

Abstract

Noncompressible hemorrhage is a leading cause of death in both combat and lay settings, primarily due to the challenges in accessing and treating injuries deep within abdominal tissues where traditional compression-based methods are ineffective. Existing hemostatic materials fail to address the needs of large wound cavities, necessitating the development of advanced materials with rapid expansion and superior hemostatic properties. Here we report an expandable hemostat engineered from a nanocomposite-coated shape memory foam. This material exhibits rapid expansion, achieving a ~5X increase in volume within 3 min in vitro, and demonstrates notable shape recovery in vivo. The material's hemostatic efficacy is evident through a ~70% reduction in clotting time compared to untreated controls, primarily due to the ability to adhere platelets and red blood cells. Moreover, the composite material displays excellent hemocompatibility and cytocompatibility, with low hemolysis rates and high cellular viability. In vivo assessments further confirm its effectiveness, showing an accelerated clotting time (~80% reduction) and decreased blood loss (~50% decrease), alongside minimal inflammation and necrosis in histological analyses. Additionally, the composite demonstrates good biocompatibility following subcutaneous implantation, illustrating its efficacy in vivo. Overall, the synergistic effect of rapid expansion by shape memory foam, along with the excellent procoagulant ability of the nanocomposite makes this biocompatible, expandable hemostat a promising treatment for noncompressible hemorrhage.

Indexed as

Biocompatible MaterialsHemorrhageHemostaticsNanocompositesAnimalsBlood CoagulationHumansMiceBiocompatible MaterialsHemostaticsbiomaterialshemostasisnanocompositenoncompressible hemorrhageshape memory

Identifiers

PMID41645718
PMCPMC13104121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.